Buy Visudyne 15 mg/1 verteporfin for injection

Visudyne 15 mg/1 is a lyophilized powder for solution used in photodynamic therapy. This verteporfin injection is designed for intravenous administration and is manufactured by Bausch & Lomb Incorporated in the USA.

Strength

15 mg/1

Pack Size

1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON (24208-560-15)

Manufacturer / TM Owner

Bausch & Lomb Incorporated

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Uses / Indications

Visudyne 15 mg/1 is primarily used in photodynamic therapy to treat certain eye conditions. This verteporfin injection is administered intravenously and is often used in procedures targeting abnormal blood vessels in the eye. The treatment involves activating the drug with a specific wavelength of light to achieve the desired therapeutic effect.

Side Effects

Common effects of Visudyne 15 mg/1 may include temporary vision changes, such as blurred vision or sensitivity to light. Some individuals may also experience injection site reactions. These effects are generally temporary and should be discussed with a healthcare provider.

Precautions & Warnings

Visudyne 15 mg/1 should be handled with care, following proper storage and administration guidelines. It is important to avoid exposure to direct sunlight or bright light after treatment, as this can increase sensitivity. Always consult a healthcare professional for specific precautions related to your condition.

Avoid Interactions

Visudyne 15 mg/1 may interact with certain medications or substances. It is advisable to avoid alcohol and other photosensitizing agents during treatment. Always inform your healthcare provider about all medications you are taking to minimize potential interactions.

References

Frequently Asked Questions

Visudyne 15 mg/1 is used in photodynamic therapy to treat certain eye conditions by targeting abnormal blood vessels.

Visudyne 15 mg/1 is administered intravenously as a lyophilized powder for solution.

Common effects may include temporary vision changes and injection site reactions.

It is advisable to avoid exposure to direct sunlight or bright light after treatment to minimize sensitivity.

Avoid alcohol and other photosensitizing agents during treatment to minimize potential interactions.

Published by GNH India Pharmaceuticals Limited

Last updated: 17 Jun 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.